Neuradiab

· Bradmer Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neuradiab, covering 2009-05-21 to 2009-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme [Phase 2]

See pricing